Test Price
2,800 AED✅ Home Collection Available
MYOT Gene LGMD1A NGS Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity for pathogenic MYOT variants via ISO 15189 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post-test interpretation and genetic counseling by a Consultant Medical Genetics.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYOT Gene Genetic Test identifies pathogenic mutations in the MYOT gene causing limb-girdle muscular dystrophy type 1A (LGMD1A), a slowly progressive autosomal dominant muscle disorder. This advanced genetic test provides definitive molecular diagnosis, informs genetic counseling, and guides targeted clinical management. Complete coding region analysis via Next Generation Sequencing (NGS) with concurrent copy number variation (CNV) detection ensures comprehensive coverage of all clinically relevant variants.
| Feature | Our MYOT NGS Test | Single-Gene Sanger Alternative |
|---|---|---|
| Method | Next Generation Sequencing (NGS) with full coding coverage & CNV detection | Targeted Sanger sequencing of known hot‑spots only |
| Diagnostic Precision | >99.9% sensitivity for all pathogenic MYOT variants | Limited to pre‑selected exons; may miss novel mutations (~60–70% yield) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I recognize the complexity that accompanies a suspected LGMD diagnosis. This test delivers definitive molecular clarity, yet results must always be interpreted alongside clinical presentation and family history. Our team ensures each report is communicated with precision and empathy.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Important Clinical Advisory
Do not stop, alter, or adjust any prescribed therapy without explicit direction from your supervising physician. This test provides diagnostic information and should not be used as a standalone guide for medication changes.
Exclusion Criteria & Emergency Red Flags
- Active acute infection or uncontrolled bleeding disorder – home collection should be deferred until resolved.
- Recent major trauma or surgical procedure at the intended venipuncture site.
- Seek immediate emergency medical attention if you experience: sudden severe muscle weakness, respiratory difficulty, choking, or acute chest pain.
Patient FAQ & Clinical Guidance
1. What does the MYOT genetic test detect?
The test detects pathogenic mutations in the MYOT gene responsible for limb-girdle muscular dystrophy type 1A with high analytical sensitivity. It analyzes the entire coding region using NGS, identifying single-nucleotide variants, small insertions or deletions, and copy number changes associated with LGMD1A. Clinically significant findings are confirmed by orthogonal Sanger sequencing when required.
2. How is the sample collected?
A standard peripheral blood sample or DNA FTA card spot is collected at your residence by a DHA-licensed VIP phlebotomist. Specimens are transported under ISO-certified cold-chain conditions directly to our CAP-accredited laboratory. No fasting or special preparation is necessary for this genetic test.
3. When will I receive my results?
Results are delivered securely within 3 to 4 weeks accompanied by a comprehensive clinical report and complimentary telephonic interpretation. Urgent preliminary findings may be communicated earlier. Genetic counseling is provided to help you and your family understand the implications of the results.
4. Is genetic counseling included with this test?
Yes, post-test genetic counseling with a Consultant Medical Genetics is included in the service fee. This session addresses the medical, psychological, and familial aspects of the diagnosis, including recurrence risks and cascade screening recommendations for at-risk relatives.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the lawful collection, processing, and storage of genetic and health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health information exchange and cybersecurity standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing the legal framework for clinical testing safety, informed consent, and patient rights.
All genetic data is encrypted, access-controlled, and retained strictly in accordance with UAE health data retention policies. DNA Labs UAE is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and holds DHA Facility License 1143.
Clinical & Logistical Metadata
| Test Name | MYOT Gene LGMD1A NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or DNA FTA Card Spot |
| Methodology Used | Next Generation Sequencing (NGS) with CNV Detection |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 21770-2 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians